CHRISTINE SCHONEFELD: Open Payments
NPI 1710664230 · EL DORADO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 29 payments from 9 companies in 2025. Trend: 2023 $17 · 2024 $103 · 2025 $654
Food & beverage: $586Education: $67
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 7 | $164 |
| Ardelyx, Inc. | 6 | $143 |
| Aurinia Pharma U.S., Inc. | 4 | $99 |
| OPKO Pharmaceuticals, LLC | 4 | $67 |
| Fresenius USA Marketing, Inc. | 3 | $60 |
| AKEBIA THERAPEUTICS INC | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: TARPEYO, IBSRELA, LUPKYNIS, RAYALDEE, VELPHORO, Vafseo, JYNARQUE, ACTHAR.
Industry payments across AR — which companies pay providers there.
